Doctors in southern Italy have been supplied with stocks of tocilizumab/Actemra to trial in Covid19 patients. It had shown good results in China - but there are so many poor quality trials that the Chinese are unable to get recruits for further work. The doctor in Naples said that they were encouraged: they gave it to 6 patients and 3 of them showed significant improvement.
Researchers at the University of Utrecht in Holland have identified an antibody. This is the first step to developing specific drugs or vaccines.